Your browser is no longer supported. Please, upgrade your browser.
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-1.26 Insider Own1.12% Shs Outstand31.62M Perf Week-5.02%
Market Cap3.82B Forward P/E- EPS next Y-0.77 Insider Trans-81.23% Shs Float30.58M Perf Month4.16%
Income- PEG- EPS next Q-0.76 Inst Own84.00% Short Float19.45% Perf Quarter21.68%
Sales220.13M P/S17.34 EPS this Y-131.30% Inst Trans0.26% Short Ratio10.05 Perf Half Y-18.07%
Book/sh23.20 P/B5.20 EPS next Y-156.70% ROA- Target Price205.29 Perf Year-20.37%
Cash/sh17.54 P/C6.88 EPS next 5Y- ROE- 52W Range95.71 - 196.00 Perf YTD15.46%
Dividend- P/FCF- EPS past 5Y- ROI-50.30% 52W High-40.16% Beta2.21
Dividend %- Quick Ratio6.60 Sales past 5Y-6.60% Gross Margin- 52W Low22.55% ATR4.82
Employees801 Current Ratio7.30 Sales Q/Q3659.10% Oper. Margin- RSI (14)45.77 Volatility3.45% 3.55%
OptionableYes Debt/Eq0.01 EPS Q/Q53.80% Profit Margin- Rel Volume0.90 Prev Close120.72
ShortableYes LT Debt/Eq0.01 EarningsFeb 25 AMC Payout- Avg Volume592.19K Price117.29
Recom1.70 SMA20-3.35% SMA503.15% SMA200-14.59% Volume313,333 Change-2.84%
Oct-30-19Initiated H.C. Wainwright Buy $170
Oct-21-19Initiated Needham Buy $200
May-07-19Upgrade Oppenheimer Perform → Outperform
May-07-19Reiterated Guggenheim Buy $186 → $222
May-07-19Reiterated Cantor Fitzgerald Overweight $196 → $229
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Feb-24-20 07:00AM  GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference GlobeNewswire
Feb-20-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
09:27AM  What's in Store for GW Pharmaceuticals' (GWPH) Q4 Earnings? Zacks
Feb-12-20 08:11AM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 31, 2019 and Host Conference Call on February 25th, 2020 GlobeNewswire
Feb-11-20 05:45PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
Feb-10-20 08:56AM  Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week Benzinga
Feb-04-20 12:02PM  BofA Sees Blockbuster Sales Potential For GW Pharma's CBD Drug Epidiolex Benzinga
08:13AM  Here's Why GW Pharmaceuticals (NASDAQ:GWPH) Can Manage Its Debt Despite Losing Money Simply Wall St.
Feb-03-20 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
07:20AM  GW Pharma submits supplemental NDA for Epidiolex to treat seizures from TSC MarketWatch
07:00AM  GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for Epidiolex® (cannabidiol) for the Treatment of Tuberous Sclerosis Complex GlobeNewswire
Jan-31-20 12:35PM  Investors Should Forget Aurora Cannabis and Buy GWPH Stock Instead InvestorPlace
Jan-28-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
02:36PM  5 'Strong Buy' Biotech Stocks to Buy for 2020 Kiplinger
Jan-19-20 12:37PM  The Week In Cannabis: Stocks Rebound Hard And Many More News Benzinga
Jan-17-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
12:19PM  Analysts: 3 Healthcare Stocks That Could Gain 35% Or More TipRanks
Jan-16-20 12:16PM  GW Pharma Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year Benzinga
Jan-15-20 12:25PM  Edited Transcript of GWPH.O earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
11:14AM  A New Bill Would Remove a CBD Roadblock for Marijuana Companies Barrons.com
Jan-14-20 09:15AM  New Records Ahead of New Trade Deal and New Earnings Season Zacks
Jan-13-20 12:47PM  GW Pharmaceutical stock rallies on better-than-expected sales forecast MarketWatch +8.91%
11:38AM  Sales Keep Growing for GW Pharmas Cannabis-Based Epilepsy Treatment Barrons.com
Jan-12-20 06:00PM  GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales GlobeNewswire
Jan-08-20 04:17PM  It's the Roaring 20's, Here's our Resolutions Zacks
Jan-07-20 01:13PM  GW Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-05-20 11:24PM  Medical cannabis: dope hope Financial Times
Dec-23-19 09:34AM  Ride the Cannabis Wave With These 3 Stocks Zacks
Dec-20-19 12:04PM  The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Aphria, Square and GW Pharmaceuticals Zacks
Dec-19-19 08:35AM  4 Marijuana Stocks to Play the Green Rush in 2020 Zacks
Dec-16-19 03:55PM  5 Health Care Stocks Gurus Are Buying GuruFocus.com
Dec-13-19 10:16AM  Five things you should know about Stephen Hahn, the new FDA commissioner MarketWatch
Dec-11-19 11:12AM  Cramer Advises His Viewers On GW Pharma, Enphase And More Benzinga
Dec-07-19 12:00PM  Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting GlobeNewswire
Dec-06-19 08:02AM  GW Pharmaceuticals (NASDAQ:GWPH) Shareholders Have Enjoyed A 43% Share Price Gain Simply Wall St.
Dec-05-19 07:00AM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting GlobeNewswire
Dec-01-19 09:30AM  The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More Benzinga
Nov-30-19 10:18AM  Cannabis stocks rocked as FDA warning undermines case for CBD investments MarketWatch
Nov-29-19 12:12PM  Canopy Growth will not be profitable by fiscal 2022, according to this analyst MarketWatch
Nov-27-19 01:35PM  CBD has the potential to harm you, FDA warns consumers MarketWatch
Nov-26-19 04:45PM  Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say Benzinga
01:07PM  Marijuana Stocks Are Slumping After the FDA Says CBD Could Harm You Barrons.com
01:07PM  CBD Has the Potential to Harm You, FDA Warns Consumers Barrons.com
07:00AM  Market Morning: CBD Warning, Chemocentryx Win, Huge Tory Majority, Amazon Injuries Market Exclusive
Nov-22-19 08:32AM  Marijuana ETFs Bounce Back: Can the Rally Last? Zacks
07:00AM  GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-21-19 11:05AM  Cannabis Short Sellers Down $272M Following Canopy Growth Upgrade Benzinga
10:10AM  What's in the Cards for OrganiGram (OGI) in Q4 Earnings? Zacks
Nov-18-19 01:02AM  New Records and New Milestones Zacks -5.48%
Nov-17-19 01:20PM  The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization Benzinga
Nov-15-19 10:21AM  Haemonetics (HAE) Grows on New Products, Robust Plasma Sales Zacks
Nov-14-19 03:49PM  Analyst: New UK Cannabis Regulations Limit Usage, Call For Additional Research Benzinga
10:38AM  GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day Zacks
09:52AM  Here's Why You Should Hold on to CVS Health (CVS) For Now Zacks
09:39AM  CVS Health's New Plans With Aetna May Improve Health Outcomes Zacks
08:36AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Nov-13-19 03:39PM  Syneos Health Collaborates with AiCure for Patient Engagement Zacks
09:56AM  Here's Why You Should Add NuVasive (NUVA) to Your Portfolio Zacks
09:46AM  Insulet Rides on Omnipod's Wider Market Reach, New Products Zacks
08:38AM  Hologic's (HOLX) 3DQuorum Imaging Technology Gets FDA Nod Zacks
07:48AM  Cronos turns lower after kicking off cannabis earnings with revenue miss MarketWatch
01:01AM  NASDAQ Hits New Record Despite Slow Session Zacks
Nov-12-19 06:37PM  UK Recommends NHS Reimburse GW Pharma's CBD-Based Epilepsy Drug Benzinga
02:01PM  Cannabis Short Sellers Up Another $190M In November Benzinga
09:41AM  Globus Medical's U.S. Spine Arm Grows, Product Launches Aid Zacks
09:41AM  Tuesday's Market Minute: The Greenest Week Of Earnings Benzinga
09:37AM  Hologic's Aptima Genitalium Assay Gets Clinically Verified Zacks
08:19AM  Medtronic (MDT) Releases Positive Study Results on Pacemaker Zacks
Nov-11-19 12:28PM  GW Pharma shares rise after UK recommends NHS reimburse its CBD-based epilepsy drug MarketWatch
10:51AM  CVS Health's Aetna Prospects Solid, Omnicare Sluggish Zacks
08:57AM  Zimmer (ZBH) Scales 52-Week High: What's Driving the Stock? Zacks
08:52AM  Myriad Genetics Presents New Test Data in Autoimmune Segment Zacks
Nov-10-19 07:01PM  GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy GlobeNewswire
Nov-08-19 05:10PM  The Week In Cannabis: Drake And Tony Hawk Get In The Weeds, Linton Joins Vireo, And A Myriad Of Earnings Benzinga
Nov-07-19 01:13AM  Stocks Take a Rest from Setting All-Time Highs Zacks
Nov-06-19 09:01PM  Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback? Zacks -17.06%
04:01PM  5 Top Stock Trades for Thursday: UBER, MTCH, KL InvestorPlace
01:45PM  Analysts Remain Upbeat On GW Pharma's Optionality With Epidiolex Benzinga
12:39PM  GW Pharma Saw Sales of Its Cannabis-Based Drug Jump. Heres Why the Stock Is Plunging. Barrons.com
08:21AM  The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings Benzinga
07:57AM  Dow Jones Futures: Xerox-HP Deal Mulled; Match Group Dives; Roku, Carvana Earnings Due Investor's Business Daily
07:43AM  Marijuana-derived epilepsy-drug sales rise 25%, but GW Pharma stock plunges more than 12% MarketWatch
06:28AM  Dow Jones Futures: 5 Big Earnings Movers After Stock Market Rally Pauses Investor's Business Daily
Nov-05-19 05:07PM  Shares Of This CBD Oil-Selling Biotech Crashed Despite Quarterly Beat Investor's Business Daily
04:35PM  GW Pharmaceuticals Reports Q3 Sales Beat, Stock Falls Benzinga
04:00PM  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019 GlobeNewswire
07:19AM  GW Pharmaceuticals Q4 Earnings Outlook Benzinga
Nov-04-19 03:38PM  Cronos paid $300 million for a small CBD company, and CEOs private-equity firm stands to collect $120 million of it MarketWatch
09:37AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
Nov-03-19 10:51AM  The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight Benzinga
Nov-01-19 12:37PM  Cramer Gives His Take On Slack, CME Group And More Benzinga
Oct-31-19 07:00AM  GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Oct-30-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
01:43PM  This Marijuana ETF Is a Smart Way to Play Aurora Cannabis Stock InvestorPlace
10:15AM  What's in Store for GW Pharmaceuticals (GWPH) in Q3 Earnings? Zacks
Oct-29-19 09:49AM  How Might Brexit Impact The UK's Cannabis Industry? Benzinga
Oct-24-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
10:11AM  Ask Our Experts: What Are The Top CBD Companies On The Market? Benzinga
Oct-23-19 04:24PM  Navigating The Healthcare Industry: Science Fiction Turns to Reality Zacks
Oct-18-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know Zacks
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gover Justin D.Chief Executive OfficerFeb 03Option Exercise0.00202,224263765,749Feb 05 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 03Sale9.62202,2241,944,678563,525Feb 05 05:00 PM
GUY GEOFFREY W DRExecutive ChairmanJan 15Sale9.44900,0008,493,0006,821,521Jan 17 05:00 PM
MACKEY CATHERINE JDirectorJan 03Sale8.541,53613,11717,748Jan 07 05:00 PM
Secor AliciaDirectorJan 03Sale8.531,53613,10217,736Jan 07 05:01 PM
Brown CabotDirectorJan 03Sale8.583,57630,68220,232Jan 07 05:01 PM
Gover Justin D.Chief Executive OfficerDec 17Option Exercise0.0010,66814568,865Dec 19 05:02 PM
Gover Justin D.Chief Executive OfficerDec 17Sale9.175,34048,968563,525Dec 19 05:02 PM
GUY GEOFFREY W DRExecutive ChairmanNov 11Sale9.33420,0003,918,6007,721,521Nov 13 05:00 PM
Snyder Douglas B.Chief Legal OfficerAug 19Sale13.045,42470,72973,740Aug 21 05:30 PM
Snyder Douglas B.Chief Legal OfficerAug 12Sale13.883,75652,13379,164Aug 14 05:30 PM
Waldegrave William A.DirectorJul 10Option Exercise0.003,57653,576Jul 11 09:00 PM
Waldegrave William A.DirectorJul 10Sale15.003,57653,6400Jul 11 09:00 PM
Snyder Douglas B.Chief Legal OfficerJul 09Sale14.424,96871,63982,920Jul 11 09:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Option Exercise3.2464,800209,95267,303Jun 05 08:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Sale14.6164,800946,7282,503Jun 05 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Option Exercise0.00202,224263743,765May 30 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Sale15.24202,2243,081,804541,541May 30 08:00 PM
Noble JamesDirectorMay 24Option Exercise4.0182,596331,347110,096May 29 08:00 PM
Noble JamesDirectorMay 24Sale15.3282,5961,265,08327,500May 29 08:00 PM
Knappertz VolkerChief Medical OfficerMay 20Sale14.6412,144177,84685,824May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 20Sale14.524,22461,33287,096May 21 08:00 PM
Knappertz VolkerChief Medical OfficerMay 18Option Exercise0.0012,1441697,968May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 18Option Exercise0.008,1361191,320May 21 08:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Option Exercise3.291,2003,9483,703May 17 07:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Sale15.011,20018,0122,503May 17 07:00 PM
Gangolli Julian SPresident, North AmericaMay 10Option Exercise2.26671,9281,517,239778,476May 14 09:00 PM
Gangolli Julian SPresident, North AmericaMay 10Sale14.84671,9289,973,283106,548May 14 09:00 PM
Tovey Christopher J.Chief Operating OfficerMay 07Option Exercise0.00200,736261203,239May 09 08:01 PM
George Adam D.SecretaryMay 07Option Exercise0.00258,324336268,324May 09 08:04 PM
George Adam D.SecretaryMay 07Sale16.10258,3244,159,01610,000May 09 08:04 PM
Tovey Christopher J.Chief Operating OfficerMay 07Sale16.14200,7363,239,8792,503May 09 08:01 PM
Gover Justin D.Chief Executive OfficerMar 15Option Exercise0.0047,85162564,960Mar 19 07:00 PM
Gover Justin D.Chief Executive OfficerMar 15Sale14.0123,400327,834541,541Mar 19 07:00 PM
MACKEY CATHERINE JDirectorMar 13Sale14.3988812,77819,284Mar 15 09:15 PM
Secor AliciaDirectorMar 13Sale14.2090012,78019,272Apr 12 05:30 PM
GUY GEOFFREY W DRExecutive ChairmanMar 04Sale14.75900,00013,275,0008,141,521Mar 05 09:05 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Option Exercise1.07576,000618,5099,041,521Mar 05 09:05 PM
Brown CabotDirectorMar 01Option Exercise3.5548,540172,21855,740Mar 05 09:09 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.38576,0008,281,2358,465,521Mar 01 08:01 PM
Brown CabotDirectorMar 01Sale14.3852,104749,0463,636Mar 05 09:09 PM
Knappertz VolkerChief Medical OfficerMar 01Sale14.463,73253,9658,736Mar 05 09:06 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.49300,0004,347,000103,925Mar 05 09:05 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Option Exercise0.0010,4041415,768Feb 28 05:00 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Option Exercise0.009,612129,612Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 26Option Exercise0.0022,44029392,885Feb 28 05:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Option Exercise0.008,4361116,608Feb 28 05:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Option Exercise0.0011,25615112,548Feb 28 05:09 PM
Gangolli Julian SPresident, North AmericaFeb 26Sale12.456,00074,696106,548Feb 28 05:09 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale12.464,14051,56812,468Feb 28 05:05 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale12.4511,112138,328381,773Feb 28 05:02 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale12.434,64457,7034,968Feb 28 05:00 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale12.455,23265,12410,536Feb 28 05:00 PM